Navigation Links
New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders
Date:3/16/2008

he world to create and validate computer-based training programs that enhance cognitive performance. Its assessments and exercises are based on neuroplasticity -- the brain's ability to "rewire" throughout life. Across a series of studies, Posit Science participants have shown clinically and statistically significant gains in memory and other cognitive measures (on average, more than 10 years of improvement). Posit Science has received several grants from the National Institutes of Health (NIH) and its patented technology has been proven effective in more than 30 published studies. The company has received numerous accolades, including designation as the Best Small Company by the American Society on Aging. For more information visit http://www.PositScience.com or call 1-800-514-3961.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Vision restoration therapy shown to improve brain activity in brain injured patients
3. Clinical depression linked to abnormal emotional brain circuits
4. Brain imaging reveals breakdown of normal emotional processing
5. Brain cells work differently than previously thought
6. Vaccine Stops Alzheimers Brain Tangles
7. Research may unlock mystery of autisms origin in the brain
8. Scientists Spot Brains Free Will Center
9. Free will takes flight: how our brains respond to an approaching menace
10. Alcoholics With Cirrhosis Have More Brain Damage
11. Brain Lesions Predict MS Progression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., TORONTO,Nov.25/PRNewswire/-SentinelleMedica...cedvisualizationsoftwarelaunchesasuiteofnewleading...ngsoftwareplatformatthisyear,sRadiologicalSocietyo...ec.5,2009(Booth5800,HallA).Theapplicationsleverage...pecializedMRIimagingcoilsandsupportmultipleimaging...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--TheBayArea...rst Winter Spare the Air Alert forTh...turedfirelogsoranyothersolidfuel,bothindoorsandout...ealthyairqualitytomorrow,"saidJackBroadbent,execut...dentstorespectthehealthoftheirneighborsandfellowco...
(Date:11/25/2009)..., A fortuitous discovery that grew out of a colla...ld potentially offer hope to the nearly 10 million...ease. , Also known as hardening of the arter...mon circulatory problem in which narrowed arteries...considered a red flag for vascular disease, heart ...
(Date:11/25/2009)... Evaluation and treatment ... Woodstock (Vocus) November 25, 2009 -- ... nasal vaccines and H1N1 vaccine shots at four Cen... another shipment of vaccine has arrived. The clin...l Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincar...n$1millionforSt.Jude.AspartofGNC,sannualSt.Jude Th...ry MISSIONSkincare,s new SUPER-C(TM)LipBalm will...eopportunitytomakea$1,$5or$10donationatcheckoutato...toraisemorethan$1millionforSt.Judeduringtheir2009 ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
... Champaign, IL June 10, 2008 Various intervention... of HIV, and a factor that might affect exposure t...nal of Applied Social Psychology reviewed the beh...men, however, were more likely to approach gender-...
...sthera Isolaz Therapy described as ,Advance Agains...poration,s,Isolaz(TM) painless acne therapy has be... & World Report, a leading national weekly news ma...leared,to treat comedonal and pustular acne, in ad...
...ared Health Clinical Xchange provides groundbreaki...0 Shared Health, Inc.,Tennessee,s largest public/...es a major system upgrade, the Shared Health Clini...Corporation and Orion Health,Systems, is releasing...
...w R&D organization to be led by SAP veteran, WAYN...d,today the formation of ICW Labs, a Silicon Valle...s use of leading technology as part of its eHealth...71126/NEM090LOGO ), The new ICW Lab is chartered...
... Smoking and body mass index (BMI) are risk factor...says one of the largest-ever studies into risk fac...e effect. The study has just been published onlin...of Audiology Congress in Hong Kong today. , Led b...
... Philadelphia, 10 June 2008 Elsevier, the world-l...cal information products and services, today intro...itles designed to fill an important niche among im...g a concise, highly readable format to make that i...
Other Medicine News:Health News:Gender affects reaction to HIV-prevention materials 2Health News:Breakthrough Isolaz(TM) Acne Therapy Featured in U.S. News & World Report: 2Health News:Shared Health(R) Announces New Data Exchange Platform 2Health News:InterComponentWare Establishes ICW Labs 2Health News:New research links smoking and body mass index to hearing loss 2Health News:New 'Expert Radiology' series fills a gap among available clinical imaging references 2
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
(Date:11/24/2009)...OODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- ...andDrugAdministration(FDA)hasacceptedforreviewEisa...#174;(donepezilHClextendedrelease)tabletsforthetre...snewhigherdoseformulationcontains23mgofdonepezilHC...ysystemthatallowsforgradualreleaseofthedrug.TheNDA...
(Date:11/24/2009)...LEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Tho...ce-basedmechanicalcirculatorysupporttherapiestosav...llbeparticipatinginthe21stAnnualPiperJaffrayHealth...ith,executivevicepresidentandchieffinancialofficer...m.,EasternStandardTime(5:30a.m.,PacificStandardTim...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Curemark Announces Senior Executive Promotions 5301 1Curemark Announces Senior Executive Promotions 5301 2Curemark Announces Senior Executive Promotions 5301 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3Potential Pieces of Autism Puzzle Revealed 59089 1Potential Pieces of Autism Puzzle Revealed 59089 2
...EY HEIGHTS, NJ – June 4, 2007 – Genta,...tion of results,from a Phase 2 clinical trial of i...injection), plus rituximab (Rituxan®;,Genentec...d or,refractory non-Hodgkin’s lymphoma (NHL)... the American Society of Clinical,Oncology (ASCO) ...
...O--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therape...cal collaborators today,reported updated Phase 2 d...n abnormal p53, tumor responses and increased,surv... recurrent,squamous cell carcinoma of the head and...day at the annual meeting of the American,Society ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4
VS II Standalone
...workflow and reduce costs associated with sample-p...tomation system. Designed for the medium- to high-...y automates labor-intensive specimen processing ta...g sample identification, centrifugation, decapping...
... Clinical is an open platform for clinical diagnos... in deck sizes of 75, 100, 150 and 200 cm that al...atory space and throughput requirements. Tecan wil...res to allow new applications and to evolve the qu...
AccelNet Laboratory Automation Network
Medicine Products: